anti brd2 (Cell Signaling Technology Inc)
86
Structured Review
Cell Signaling Technology Inc
anti brd2
Anti Brd2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd2/pm41942733-275-38-40
Average 86 stars, based on 1 article reviews
Anti Brd2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd2/pm41942733-275-38-40
Average 86 stars, based on 1 article reviews
anti brd2 - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
other:Article Title: Inhibition of BRD proteins suppresses the phenotype of uterine fibroids Article Snippet: Specific protein bands were visualized using ChemiDoc XRS molecular imager (Bio-Rad, Hercules, CA, USA). Article Title: A triple-action PROTAC for wild-type p53 cancer therapy Article Snippet: PBMCs were cultured overnight (19 h) with a 10 μM top dose, 7-point, 2-fold dilution curve of TAPTAC1 or A1874 (Selleckchem, #S8785), or 0.1% DMSO vehicle (Sigma D2650-100ML) control in a total volume of 100 μL. Saline:Article Title: A triple-action PROTAC for wild-type p53 cancer therapy. Article Snippet: For the proteasome inhibition experiment, SJSA-X cells were cultured, treated with TAPTAC1, and processed as above except that bortezomib (50 nM) was added and assessment time points were at 4, 8, and 24 h and 3–8% TrisAcetate SDS-PAGE gels (Invitrogen) were used for electrophoresis. .. The membranes were blocked in a solution of 5% milk prepared in PBS-T (Phosphate Buffered Saline, 0.01% Tween) and incubated with primary antibodies overnight at 4 ◦ C, 1:1000 in 3% BSA (p53 [Millipore, #OP43-100UG, RRID: AB_10682938], p21 [Cell Signaling Technology, #2947, RRID: AB_823586], HDM2 [Millipore, #OP46-100UG, RRID: AB_10681293], HDMX [Fortis Life Sciences, #A300-287A, RRID: AB_263407], actin [Sigma, #A1978, RRID: AB_476692]) or 5% milk prepared in PBS-T (BRD4 [Cell Signaling Technology, #13440, RRID: AB_2687578]; BRD3 [Cell Signaling Technology, #94032]; Incubation:Article Title: A triple-action PROTAC for wild-type p53 cancer therapy. Article Snippet: For the proteasome inhibition experiment, SJSA-X cells were cultured, treated with TAPTAC1, and processed as above except that bortezomib (50 nM) was added and assessment time points were at 4, 8, and 24 h and 3–8% TrisAcetate SDS-PAGE gels (Invitrogen) were used for electrophoresis. .. The membranes were blocked in a solution of 5% milk prepared in PBS-T (Phosphate Buffered Saline, 0.01% Tween) and incubated with primary antibodies overnight at 4 ◦ C, 1:1000 in 3% BSA (p53 [Millipore, #OP43-100UG, RRID: AB_10682938], p21 [Cell Signaling Technology, #2947, RRID: AB_823586], HDM2 [Millipore, #OP46-100UG, RRID: AB_10681293], HDMX [Fortis Life Sciences, #A300-287A, RRID: AB_263407], actin [Sigma, #A1978, RRID: AB_476692]) or 5% milk prepared in PBS-T (BRD4 [Cell Signaling Technology, #13440, RRID: AB_2687578]; BRD3 [Cell Signaling Technology, #94032]; Cell-Signaling:Article Title: High-throughput in silico screen uncovers key regulators of 3D genome architecture Article Snippet: .. The primary antibody used for IP included: FLAG (Sigma-Aldrich, F1804), CTCF (Diagenode, C15410210), RAD21 (abcam, ab992), SMC1 (ThermoFisher, A300-055A), SMC3 (abcam, ab9263), STAG1 (abcam, ab4457), STAG2 (abcam, ab4464), Control:Article Title: High-throughput in silico screen uncovers key regulators of 3D genome architecture Article Snippet: .. The primary antibody used for IP included: FLAG (Sigma-Aldrich, F1804), CTCF (Diagenode, C15410210), RAD21 (abcam, ab992), SMC1 (ThermoFisher, A300-055A), SMC3 (abcam, ab9263), STAG1 (abcam, ab4457), STAG2 (abcam, ab4464), Chromatin Immunoprecipitation:Article Title: BRD2 bridges TFIID and MOF-H4K16ac-containing nucleosomes to promote transcriptional initiation. Article Snippet: Article |
